114 related articles for article (PubMed ID: 21256254)
1. Bisphosphonates in orthopedic applications.
Wilkinson JM; Little DG
Bone; 2011 Jul; 49(1):95-102. PubMed ID: 21256254
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates: the first 40 years.
Russell RG
Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003
[TBL] [Abstract][Full Text] [Related]
3. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don't know.
Allen MR; Burr DB
Bone; 2011 Jul; 49(1):56-65. PubMed ID: 20955825
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates do not inhibit periosteal bone formation in estrogen deficient animals and allow enhanced bone modeling in response to mechanical loading.
Feher A; Koivunemi A; Koivunemi M; Fuchs RK; Burr DB; Phipps RJ; Reinwald S; Allen MR
Bone; 2010 Jan; 46(1):203-7. PubMed ID: 19857619
[TBL] [Abstract][Full Text] [Related]
6. Anabolic effects of bisphosphonates on peri-implant bone stock.
von Knoch F; Eckhardt C; Alabre CI; Schneider E; Rubash HE; Shanbhag AS
Biomaterials; 2007 Aug; 28(24):3549-59. PubMed ID: 17498799
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.
Baas J
Acta Orthop Suppl; 2008 Aug; 79(330):1-43. PubMed ID: 19065776
[TBL] [Abstract][Full Text] [Related]
8. [Effects of bisphosphonates in arthroplasty].
Brankamp J; Eberhardt C; Landgräber S; von Knoch M; Saxler G; Löer F; Kurth AA
Z Orthop Ihre Grenzgeb; 2006; 144(2):187-91. PubMed ID: 16625449
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of bisphosphonates.
Green JR
Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
[TBL] [Abstract][Full Text] [Related]
12. The backbone of progress--preclinical studies and innovations with zoledronic acid.
Green JR; Guenther A
Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S3-S12. PubMed ID: 21353178
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty.
Zhu L; Zheng W; Zhao FC; Guo Y; Meng BY; Liu HT; Guo KJ
J Orthop Sci; 2013 Sep; 18(5):762-73. PubMed ID: 23728892
[TBL] [Abstract][Full Text] [Related]
14. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
McDonald MM; Dulai S; Godfrey C; Amanat N; Sztynda T; Little DG
Bone; 2008 Oct; 43(4):653-62. PubMed ID: 18582604
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH
Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors.
Mont MA; Jones LC; Einhorn TA; Hungerford DS; Reddi AH
Clin Orthop Relat Res; 1998 Oct; (355 Suppl):S314-35. PubMed ID: 9917651
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle.
Bertoldo F; Santini D; Lo Cascio V
Nat Clin Pract Oncol; 2007 Dec; 4(12):711-21. PubMed ID: 18037875
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins in total hip arthroplasty, osteonecrosis and trauma surgery.
Stiehl JB; Ulrich SD; Seyler TM; Bonutti PM; Marker DR; Mont MA
Expert Rev Med Devices; 2008 Mar; 5(2):231-8. PubMed ID: 18331183
[TBL] [Abstract][Full Text] [Related]
20. [Preclinical toxicology of bisphosphonates].
Mondelo N; Peluffo VA; Parma MD; Cointry GR; Capozza RF; Ferretti JL; Piccinni E; Montuori E
Medicina (B Aires); 1997; 57 Suppl 1():93-100. PubMed ID: 9567361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
